Meeting Coverage
HIV Glasgow
The International Congress on Drug Therapy in HIV Infection
Dolutegravir efficacy non-inferior to efavirenz-based regimen at week 48
Latest HIV Glasgow Meeting Coverage
Fostemsavir maintained virologic response through week 48 in ongoing phase III trial
November 1, 2018
Week 96 results continue to show non-inferiority in treatment-naive HIV+ adults
October 31, 2018
Literature shows prevalence of mental health, depression in this population
October 31, 2018
Look to oncology space for benchmarks, immunotherapy research, experts say
October 30, 2018
No significant difference in grade 3/4 adverse events, meta-analysis finds
October 30, 2018
Substudy finds competing markers of decreased, increased risk of CV events
October 29, 2018
Latest HIV/AIDS Meeting Coverage
-
IAC: International AIDS Conference
July 2024
-
IAS: IAS Conference on HIV Science
July 2023
-
ANAC: Association of Nurses in AIDS Care
November 2019
-
HIV Glasgow: The International Congress on Drug Therapy in HIV Infection
October 2018